Literature DB >> 21885669

Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.

Kyle Ware1, Polina Brodsky, Anjali A Satoskar, Tibor Nadasdy, Gyongyi Nadasdy, Haifeng Wu, Brad H Rovin, Udayan Bhatt, Jon Von Visger, Lee A Hebert, Sergey V Brodsky.   

Abstract

An acute increase in international normalized ratio (INR) to >3.0 in patients with chronic kidney disease (CKD) can associate with an unexplained acute increase in serum creatinine and accelerated progression of CKD. A subset of these patients have renal tubular obstruction by casts of red blood cells, presumably the dominant mechanism of the acute kidney injury described as warfarin-related nephropathy. Here, we developed an animal model of this acute kidney injury that is based on the 5/6-nephrectomy model to aid future investigation of the pathogenesis of this condition. We found that acute excessive anticoagulation with brodifacoum ("superwarfarin") increased serum creatinine levels and hematuria in 5/6-nephrectomized rats but not in controls. In addition, morphologic findings in 5/6-nephrectomized rats included glomerular hemorrhage, occlusive red blood cell casts, and acute tubular injury, similar to the biopsy findings among affected patients. Furthermore, in the rat model, we observed an increase in apoptosis of glomerular endothelial cells. In summary, the 5/6-nephrectomy model combined with excessive anticoagulation may be a useful tool to study the pathogenesis of warfarin-related nephropathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21885669      PMCID: PMC3279947          DOI: 10.1681/ASN.2010101110

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  12 in total

Review 1.  Gas6, warfarin, and kidney diseases.

Authors:  Motoko Yanagita
Journal:  Clin Exp Nephrol       Date:  2004-12       Impact factor: 2.801

2.  Mechanism of inhibitory effect of warfarin on mesangial cell proliferation.

Authors:  M Yanagita; K Ishii; H Ozaki; H Arai; T Nakano; K Ohashi; K Mizuno; T Kita; T Doi
Journal:  J Am Soc Nephrol       Date:  1999-12       Impact factor: 10.121

3.  Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

Authors:  Sergey V Brodsky; Tibor Nadasdy; Brad H Rovin; Anjali A Satoskar; Gyongyi M Nadasdy; Haifeng M Wu; Udayan Y Bhatt; Lee A Hebert
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

4.  Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.

Authors:  Yan-Guang Cao; Xiao-Quan Liu; Yuan-Cheng Chen; Kun Hao; Guang-Ji Wang
Journal:  Eur J Pharm Sci       Date:  2006-11-07       Impact factor: 4.384

5.  Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction.

Authors:  K A Griffin; A K Bidani; J Ouyang; V Ellis; M Churchill; P C Churchill
Journal:  Am J Physiol       Date:  1993-06

6.  Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

Authors:  Sergey V Brodsky; Anjali Satoskar; Jun Chen; Gyongyi Nadasdy; Jeremiah W Eagen; Mirza Hamirani; Lee Hebert; Edward Calomeni; Tibor Nadasdy
Journal:  Am J Kidney Dis       Date:  2009-07-04       Impact factor: 8.860

7.  Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.

Authors:  Micky J Chun; Stephen M Korbet; Melvin M Schwartz; Edmund J Lewis
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

8.  Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.

Authors:  D B Thomas; N Franceschini; S L Hogan; S Ten Holder; C E Jennette; R J Falk; J C Jennette
Journal:  Kidney Int       Date:  2006-03       Impact factor: 10.612

9.  Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury.

Authors:  K A Griffin; M Picken; A K Bidani
Journal:  J Am Soc Nephrol       Date:  1994-06       Impact factor: 10.121

10.  Role of growth hormone in the development of experimental renal scarring.

Authors:  A M el Nahas; A H Bassett; G H Cope; J E Le Carpentier
Journal:  Kidney Int       Date:  1991-07       Impact factor: 10.612

View more
  36 in total

Review 1.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

2.  Anticoagulant-Related Nephropathy: It's the Real McCoy.

Authors:  Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-21       Impact factor: 8.237

Review 3.  The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures.

Authors:  Douglas L Feinstein; Belinda S Akpa; Manuela A Ayee; Anne I Boullerne; David Braun; Sergey V Brodsky; David Gidalevitz; Zane Hauck; Sergey Kalinin; Kathy Kowal; Ivan Kuzmenko; Kinga Lis; Natalia Marangoni; Michael W Martynowycz; Israel Rubinstein; Richard van Breemen; Kyle Ware; Guy Weinberg
Journal:  Ann N Y Acad Sci       Date:  2016-05-31       Impact factor: 5.691

4.  5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy.

Authors:  A Ozcan; K Ware; E Calomeni; T Nadasdy; R Forbes; A A Satoskar; G Nadasdy; B H Rovin; L A Hebert; S V Brodsky
Journal:  Am J Nephrol       Date:  2012-04-02       Impact factor: 3.754

5.  Supratherapeutic International Normalized Ratio causing Nephropathy: A Rare Adverse Effect of Warfarin.

Authors:  Muhammad Shabbir Rawala; Amna Saleem Ahmed; Muhammad Y Khan; Muhammad Nauman Riaz; Amr Eltoukhy
Journal:  Cureus       Date:  2019-07-22

6.  Recommendations for the use of new oral anticoagulants (NOACs) after TIA or stroke caused by atrial fibrillation (AF), after a consensus conference among Italian neurologists (the Venice group).

Authors:  Vito Toso
Journal:  Neurol Sci       Date:  2013-12-10       Impact factor: 3.307

7.  Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study.

Authors:  Siavash Piran; Hugh Traquair; Noel Chan; Marlene Robinson; Sam Schulman
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

Review 8.  Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.

Authors:  Mauro Molteni; Mario Bo; Giovanni Di Minno; Giuseppe Di Pasquale; Simonetta Genovesi; Danilo Toni; Paolo Verdecchia
Journal:  Intern Emerg Med       Date:  2017-04-24       Impact factor: 3.397

Review 9.  Oral anticoagulants and risk of nephropathy.

Authors:  Vinay Narasimha Krishna; David G Warnock; Nakshatra Saxena; Dana V Rizk
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

10.  The Long-Lasting Rodenticide Brodifacoum Induces Neuropathology in Adult Male Rats.

Authors:  Sergey Kalinin; Natalia Marangoni; Katarzyna Kowal; Arunangsu Dey; Kinga Lis; Sergey Brodsky; Richard van Breemen; Zane Hauck; Richard Ripper; Israel Rubinstein; Guy Weinberg; Douglas L Feinstein
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.